Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial

Device-detected subclinical atrial fibrillation (AF) refers to infrequent, short-lasting, asymptomatic AF that is detected only with long-term continuous monitoring. Subclinical AF is common and associated with an increased risk of stroke; however, the risk of stroke with subclinical AF is lower tha...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal Jg. 189; S. 137 - 145
Hauptverfasser:	Lopes, Renato D., Alings, Marco, Connolly, Stuart J., Beresh, Heather, Granger, Christopher B., Mazuecos, Juan Benezet, Boriani, Giuseppe, Nielsen, Jens C., Conen, David, Hohnloser, Stefan H., Mairesse, Georges H., Mabo, Philippe, Camm, A. John, Healey, Jeffrey S.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Elsevier Inc 01.07.2017 Elsevier Limited
Schlagworte:	Administration, Oral Aged Anticoagulants Aspirin Atrial Fibrillation - complications Atrial Fibrillation - diagnosis Atrial Fibrillation - therapy Cardiac arrhythmia Cardiovascular Cerebral infarction Clinical trials Dose-Response Relationship, Drug Double-Blind Method EKG Electrocardiography Embolism Embolisms Factor Xa Inhibitors - administration & dosage Female Fibrillation Follow-Up Studies Heart Heart diseases Humans Infarction Ischemia Magnetic resonance imaging Male Middle Aged Mortality Pacemaker, Artificial Patients Prevention Prospective Studies Pyrazoles - administration & dosage Pyridones - administration & dosage Randomization Risk analysis Risk factors Stroke Thromboembolism Thromboembolism - etiology Thromboembolism - prevention & control Transient ischemic attack Trends
ISSN:	0002-8703, 1097-6744, 1097-6744
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!